152 related articles for article (PubMed ID: 34402883)
1. Loss of erythroblasts in acute myeloid leukemia causes iron redistribution with clinical implications.
Lopes M; Duarte TL; Teles MJ; Mosteo L; Chacim S; Aguiar E; Pereira-Reis J; Oliveira M; Silva AMN; Gonçalves N; Martins G; Kong IY; Zethoven M; Vervoort S; Martins S; Quintela M; Hawkins ED; Trigo F; Guimarães JT; Mariz JM; Porto G; Duarte D
Blood Adv; 2021 Aug; 5(16):3102-3112. PubMed ID: 34402883
[TBL] [Abstract][Full Text] [Related]
2. Iron overload promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of FOS.
Yang F; Cui X; Wang H; Zhang D; Luo S; Li Y; Dai Y; Yang D; Zhang X; Wang L; Zheng G; Zhang X
Cancer Lett; 2024 Feb; 583():216652. PubMed ID: 38242196
[TBL] [Abstract][Full Text] [Related]
3. The Importance of Log Ferritin and Transferrin /Log Ferritin in Differentiating Iron Deficiency Anemia from Anemia of Chronic Disease in Rheumatoid Arthritis Patients.
Abdel-Noor RA; Abu-Zaid MH; Elshweikh SA; Rabee ES; Khedr GE
Egypt J Immunol; 2019 Jan; 26(1):141-150. PubMed ID: 31333004
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of low transferrin saturation in patients with primary myelofibrosis.
Lucijanic M; Prka Z; Pejsa V; Stoos-Veic T; Lucijanic J; Kusec R
Leuk Res; 2018 Mar; 66():89-95. PubMed ID: 29407589
[TBL] [Abstract][Full Text] [Related]
5. Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model.
Liu Q; Chen L; Atkinson JM; Claxton DF; Wang HG
Cell Death Dis; 2016 Sep; 7(9):e2361. PubMed ID: 27607576
[TBL] [Abstract][Full Text] [Related]
6. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W
Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381
[TBL] [Abstract][Full Text] [Related]
7. A reduced transferrin saturation is independently associated with excess morbidity and mortality in older adults with heart failure and incident anemia.
Ambrosy AP; Fitzpatrick JK; Tabada GH; Gurwitz JH; Artz A; Schrier SL; Rao SV; Reynolds K; Smith DH; Peterson PN; Fortmann SP; Sung SH; Cohen HJ; Go AS;
Int J Cardiol; 2020 Jun; 309():95-99. PubMed ID: 32201101
[TBL] [Abstract][Full Text] [Related]
8. Transient potential receptor melastatin-2 (Trpm2) does not influence murine MLL-AF9-driven AML leukemogenesis or in vitro response to chemotherapy.
Haladyna JN; Pastuer T; Riedel SS; Perraud AL; Bernt KM
Exp Hematol; 2016 Jul; 44(7):596-602.e3. PubMed ID: 27033163
[TBL] [Abstract][Full Text] [Related]
9. Low serum transferrin correlates with acute-on-chronic organ failure and indicates short-term mortality in decompensated cirrhosis.
Bruns T; Nuraldeen R; Mai M; Stengel S; Zimmermann HW; Yagmur E; Trautwein C; Stallmach A; Strnad P
Liver Int; 2017 Feb; 37(2):232-241. PubMed ID: 27473364
[TBL] [Abstract][Full Text] [Related]
10. MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome.
Stavropoulou V; Kaspar S; Brault L; Sanders MA; Juge S; Morettini S; Tzankov A; Iacovino M; Lau IJ; Milne TA; Royo H; Kyba M; Valk PJM; Peters AHFM; Schwaller J
Cancer Cell; 2016 Jul; 30(1):43-58. PubMed ID: 27344946
[TBL] [Abstract][Full Text] [Related]
11. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
[TBL] [Abstract][Full Text] [Related]
12. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
[TBL] [Abstract][Full Text] [Related]
13. Loss of Dnmt3b accelerates MLL-AF9 leukemia progression.
Zheng Y; Zhang H; Wang Y; Li X; Lu P; Dong F; Pang Y; Ma S; Cheng H; Hao S; Tang F; Yuan W; Zhang X; Cheng T
Leukemia; 2016 Dec; 30(12):2373-2384. PubMed ID: 27133822
[TBL] [Abstract][Full Text] [Related]
14. High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patients.
Noordermeer SM; Sanders MA; Gilissen C; Tönnissen E; van der Heijden A; Döhner K; Bullinger L; Jansen JH; Valk PJ; van der Reijden BA
Blood; 2011 Nov; 118(20):5613-21. PubMed ID: 21937695
[TBL] [Abstract][Full Text] [Related]
15. Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia.
Gao Y; Gao J; Li M; Zheng Y; Wang Y; Zhang H; Wang W; Chu Y; Wang X; Xu M; Cheng T; Ju Z; Yuan W
J Hematol Oncol; 2016 Apr; 9():36. PubMed ID: 27071307
[TBL] [Abstract][Full Text] [Related]
16. Id2 and E Proteins Orchestrate the Initiation and Maintenance of MLL-Rearranged Acute Myeloid Leukemia.
Ghisi M; Kats L; Masson F; Li J; Kratina T; Vidacs E; Gilan O; Doyle MA; Newbold A; Bolden JE; Fairfax KA; de Graaf CA; Firth M; Zuber J; Dickins RA; Corcoran LM; Dawson MA; Belz GT; Johnstone RW
Cancer Cell; 2016 Jul; 30(1):59-74. PubMed ID: 27374225
[TBL] [Abstract][Full Text] [Related]
17. Low transferrin saturation (TSAT) and high ferritin levels are significant predictors for cerebrovascular and cardiovascular disease and death in maintenance hemodialysis patients.
Kuragano T; Joki N; Hase H; Kitamura K; Murata T; Fujimoto S; Fukatsu A; Inoue T; Itakura Y; Nakanishi T
PLoS One; 2020; 15(9):e0236277. PubMed ID: 32877424
[TBL] [Abstract][Full Text] [Related]
18. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
[TBL] [Abstract][Full Text] [Related]
19. Impact of Transferrin Saturation on All-Cause Mortality in Patients on Maintenance Hemodialysis.
Sato M; Hanafusa N; Tsuchiya K; Kawaguchi H; Nitta K
Blood Purif; 2019; 48(2):158-166. PubMed ID: 31311016
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
